Logo image of ALAGR.PA

AGROGENERATION (ALAGR.PA) Stock Fundamental Analysis

EPA:ALAGR - Euronext Paris - Matif - FR0010641449 - Common Stock - Currency: EUR

0.069  0 (-5.22%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ALAGR. ALAGR was compared to 58 industry peers in the Food Products industry. ALAGR may be in some trouble as it scores bad on both profitability and health. ALAGR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALAGR has reported negative net income.
In the past year ALAGR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ALAGR reported negative net income in multiple years.
ALAGR had a positive operating cash flow in 4 of the past 5 years.
ALAGR.PA Yearly Net Income VS EBIT VS OCF VS FCFALAGR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -11.44%, ALAGR is doing worse than 86.21% of the companies in the same industry.
Looking at the Return On Equity, with a value of -31.17%, ALAGR is doing worse than 86.21% of the companies in the same industry.
ALAGR has a Return On Invested Capital of 1.99%. This is in the lower half of the industry: ALAGR underperforms 77.59% of its industry peers.
Industry RankSector Rank
ROA -11.44%
ROE -31.17%
ROIC 1.99%
ROA(3y)-31.43%
ROA(5y)-26.1%
ROE(3y)-85.75%
ROE(5y)-69.89%
ROIC(3y)N/A
ROIC(5y)N/A
ALAGR.PA Yearly ROA, ROE, ROICALAGR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

With a Operating Margin value of 3.31%, ALAGR is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of ALAGR has declined.
ALAGR's Gross Margin of 22.23% is on the low side compared to the rest of the industry. ALAGR is outperformed by 74.14% of its industry peers.
ALAGR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.31%
PM (TTM) N/A
GM 22.23%
OM growth 3Y-19.56%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.59%
GM growth 5Y43.69%
ALAGR.PA Yearly Profit, Operating, Gross MarginsALAGR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALAGR is destroying value.
Compared to 1 year ago, ALAGR has about the same amount of shares outstanding.
Compared to 5 years ago, ALAGR has more shares outstanding
The debt/assets ratio for ALAGR has been reduced compared to a year ago.
ALAGR.PA Yearly Shares OutstandingALAGR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
ALAGR.PA Yearly Total Debt VS Total AssetsALAGR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

ALAGR has an Altman-Z score of -7.36. This is a bad value and indicates that ALAGR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALAGR (-7.36) is worse than 87.93% of its industry peers.
ALAGR has a debt to FCF ratio of 11.27. This is a negative value and a sign of low solvency as ALAGR would need 11.27 years to pay back of all of its debts.
ALAGR has a Debt to FCF ratio of 11.27. This is in the lower half of the industry: ALAGR underperforms 67.24% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that ALAGR is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, ALAGR is not doing good in the industry: 60.34% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 11.27
Altman-Z -7.36
ROIC/WACC0.49
WACC4.05%
ALAGR.PA Yearly LT Debt VS Equity VS FCFALAGR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

ALAGR has a Current Ratio of 1.08. This is a normal value and indicates that ALAGR is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.08, ALAGR is not doing good in the industry: 68.97% of the companies in the same industry are doing better.
ALAGR has a Quick Ratio of 1.08. This is a bad value and indicates that ALAGR is not financially healthy enough and could expect problems in meeting its short term obligations.
ALAGR has a Quick ratio of 0.19. This is amonst the worse of the industry: ALAGR underperforms 96.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 0.19
ALAGR.PA Yearly Current Assets VS Current LiabilitesALAGR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

0

3. Growth

3.1 Past

ALAGR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.60%, which is quite impressive.
The Revenue for ALAGR has decreased by -12.58% in the past year. This is quite bad
Measured over the past years, ALAGR shows a very negative growth in Revenue. The Revenue has been decreasing by -16.23% on average per year.
EPS 1Y (TTM)66.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.33%
Revenue 1Y (TTM)-12.58%
Revenue growth 3Y-24.4%
Revenue growth 5Y-16.23%
Sales Q2Q%-12.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALAGR.PA Yearly Revenue VS EstimatesALAGR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ALAGR.PA Yearly EPS VS EstimatesALAGR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

1

4. Valuation

4.1 Price/Earnings Ratio

ALAGR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALAGR.PA Price Earnings VS Forward Price EarningsALAGR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALAGR is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, ALAGR is valued a bit cheaper than 72.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.3
EV/EBITDA 6.61
ALAGR.PA Per share dataALAGR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALAGR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AGROGENERATION

EPA:ALAGR (3/7/2025, 7:00:00 PM)

0.069

0 (-5.22%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.29M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.96
P/FCF 10.3
P/OCF 7.27
P/B 1.29
P/tB 1.29
EV/EBITDA 6.61
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY9.71%
OCF(TTM)0.01
OCFY13.75%
SpS0.07
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.44%
ROE -31.17%
ROCE 2.7%
ROIC 1.99%
ROICexc 2.11%
ROICexgc 2.12%
OM 3.31%
PM (TTM) N/A
GM 22.23%
FCFM 9.37%
ROA(3y)-31.43%
ROA(5y)-26.1%
ROE(3y)-85.75%
ROE(5y)-69.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-24.2%
ROICexcg growth 5YN/A
ROICexc growth 3Y-17.64%
ROICexc growth 5YN/A
OM growth 3Y-19.56%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.59%
GM growth 5Y43.69%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 11.27
Debt/EBITDA 1.57
Cap/Depr 14.44%
Cap/Sales 3.89%
Interest Coverage 6.24
Cash Conversion 43.83%
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 0.19
Altman-Z -7.36
F-Score5
WACC4.05%
ROIC/WACC0.49
Cap/Depr(3y)25.01%
Cap/Depr(5y)21.52%
Cap/Sales(3y)4.95%
Cap/Sales(5y)4.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.58%
Revenue growth 3Y-24.4%
Revenue growth 5Y-16.23%
Sales Q2Q%-12.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2520%
EBIT growth 3Y-39.18%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-90.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.07%
OCF growth 3Y-65.36%
OCF growth 5Y-47.17%